Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

Early predictors of 30-day mortality in supratentorial ischemic stroke patients--firstepisode.

A Szczudiik, A Słowik, W Turaj, G Zwolińska, U Wyrwicz-Petkow, K Kasprzyk, M Bosak

Med Sci Monit 2000; 6(1): CR75-80 :: ID: 432826

Abstract

INTRODUCTION: Prognostic factors following stroke remain to be established.The aim of this study was to determine early prognostic factors related with a 30-day mortality in firstepisode ischemic stroke patients. MATERIALS AND METHODS: The study group comprised 329 consecutive patients,aged between 33 and 99 years (mean age +/- SD 69 +/- 12.6) admitted within 24 hours following their firstsupratentorial ischemic stroke, confirmed either by computer tomography (CT) and/or autopsy. The followingdata were assessed within 24 hours of hospitalization: gender, age, history of diabetes mellitus, historyof ischemic heart disease, obesity, the neurological deficit at entry and after one day, level of consciousnessat entry and after one day, electrocardiographic dysrhythmia at entry, blood pressure at entry and bodytemperature on the first day following stroke. We also assessed particular serum biochemical and hematologicalmarkers including: hematocrit, fibrinogen concentration, platelet count, white blood cell (WBC) count,gamma globulin level, glucose level, cholesterol level, the erythrocyte sedimentation rate (ESR), andcreatinine kinase (CK) level. The end-point for assessment was early death (within 30 days). Statisticalanalysis consisted of univariate analysis and multiple regression. RESULTS: Univariate analysis demonstratedthat an older age, increased neurological deficit at entry and on the next day, decreased consciousnessat entry and on the next day, electrocardiographic dysrhythmia, increased body temperature and glucoselevel, decreased cholesterol level and increased CK level were significantly associated with death after30 days (p < or = 0.05). During multivariate analysis, only a severe neurological deficit (ScandinavianStroke Scale < or = 15 points) both at entry and on the next day (OR = 8.3; 95% CI: 2.83-24.35), decreasedconsciousness within the first 24 hours of hospitalization (OR = 19.2; 95% CI: 2.84-127.77) and electrocardiographicdysrhythmia (OR = 5.2; 95% CI: 2.37-13.77) were associated with death after 30 days. CONCLUSION: A severeneurological deficit lasting 24 hours, decreased consciousness within 24 hours of hospitalization andelectrocardiographic dysrhythmia are the most important indicators of 30-day mortality in patients withfirst-time ischemic stroke.

Keywords: Time Factors

Add Comment 0 Comments

Editorial

01 January 2025 : Editorial  

Editorial: The Human Cell Atlas. What Is It and Where Could It Take Us?

Dinah V. Parums

DOI: 10.12659/MSM.947707

Med Sci Monit 2025; 31:e947707

0:00

In Press

Clinical Research  

Impact of Smovey Vibration Versus Dumbbell Resistance on Muscle Activation in Women

Med Sci Monit In Press; DOI: 10.12659/MSM.946567  

Clinical Research  

Five-Year Impact of Weight Loss on Knee Pain and Quality of Life in Obese Patients

Med Sci Monit In Press; DOI: 10.12659/MSM.946550  

Clinical Research  

Butorphanol Tartrate Nasal Spray for Post-Cesarean Analgesia and Prolactin Secretion

Med Sci Monit In Press; DOI: 10.12659/MSM.945224  

Database Analysis  

Role of the Carhart Effect and Outcomes from Surgery: A Retrospective Study of 532 Patients with Conductive...

Med Sci Monit In Press; DOI: 10.12659/MSM.947061  

Most Viewed Current Articles

17 Jan 2024 : Review article   6,963,045

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   700,086

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   23,449

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   18,141

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750